While others wait for change to come,
we choose to leap.

Because disease doesn’t wait, neither do we. And so together, with our partners and the patients we serve at our side, we’re marching ahead. Turning one-size-fits-all treatment into personalized medicine for all. C’mon. Let’s leap.


A leap in treatment options
and innovations ready to explore.

Discover all the ways we’re bridging care and research to deliver better patient-centered outcomes.
Find the latest research about our ongoing Clinical Trials including: publications, featured news, Schemas, and more.
See our latest projects and collaborations with our pharma and community health partners.
Your donation makes all the difference. As a 501C(3) charitable organization, your financial support of any amount helps us advance our innovative, lifesaving work.

A leap that’s saving lives.

Dr. Laura Esserman alongside Quantum is challenging the status quo with the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (RECAST DCIS) study. This Phase 2 platform study seeks to shift the paradigm of standard treatment of care and perception of DCIS as an invasive cancer and instead aims at preventing the progression of DCIS to breast cancer.

Find the latest leaps happening near you.

Our innovative cancer trials are all happening over making positive breakthroughs every day in the advancement of patient outcomes. Use our helpful map to find the latest ones near you.

A leap in research happens with world-class partners.

Together with our incredible partners in the pharma and healthcare world,
we’re making bigger leaps than ever before to advance personalized medicine for all.

Contact Us
Investigators Portal
QLHC in the News
Working at QL
Contact Us